Table 2, Characteristics of Included Guidelines - Sequencing of Pharmacological Management of Crohn’s Disease and Ulcerative Colitis: A Review of Guidelines

Guideline Development Group, Year	Scope and Interventions	Target Population; Intended users	Evidence Collection, Selection, and Synthesis	Recommendations Development and Evaluation	Grading system
Canadian Association of Gastroenterology,³⁰ Canada, Steinhart, et al. 2019	Guideline for the medical management of perianal fistulizing Crohn’s disease Interventions: medical management for the condition	Adults and children with perianal fistulizing Crohn’s disease; Intended users assumed to be those providing multidisciplinary medical management for those with perianal fistulising Crohn’s disease	Systematic structured evidence review done by the Canadian Association of Gastroenterology (literature search up to April 2016 for MEDLINE, EMBASE, CENTRAL)	Statements were developed through an iterative online platform using a modified Delphi process, then finalized, and voted on by a group of specialists.	The evidence and recommendation rating were adopted from the classification developed by the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) workgroup. The GRADE system primarily involves consideration of the following factors: overall study quality (or overall risk of bias or study limitations), consistency of evidence, directness of evidence, and precision of evidence.

Guideline Development Group, Year

Scope and Interventions

Target Population; Intended users

Evidence Collection, Selection, and Synthesis

Recommendations Development and Evaluation

Grading system

Canadian Association of Gastroenterology,³⁰ Canada, Steinhart, et al. 2019

Guideline for the medical management of perianal fistulizing Crohn’s disease

Interventions: medical management for the condition

Adults and children with perianal fistulizing Crohn’s disease;

Intended users assumed to be those providing multidisciplinary medical management for those with perianal fistulising Crohn’s disease

Systematic structured evidence review done by the Canadian Association of Gastroenterology (literature search up to April 2016 for MEDLINE, EMBASE, CENTRAL)

Statements were developed through an iterative online platform using a modified Delphi process, then finalized, and voted on by a group of specialists.

The evidence and recommendation rating were adopted from the classification developed by the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) workgroup.

The GRADE system primarily involves consideration of the following factors: overall study quality (or overall risk of bias or study limitations), consistency of evidence, directness of evidence, and precision of evidence.

From: Sequencing of Pharmacological Management of Crohn’s Disease and Ulcerative Colitis: A Review of Guidelines

Cover of Sequencing of Pharmacological Management of Crohn’s Disease and Ulcerative Colitis: A Review of Guidelines

Sequencing of Pharmacological Management of Crohn’s Disease and Ulcerative Colitis: A Review of Guidelines [Internet].

Ho C, Argáez C.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jan 31.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Table 2Characteristics of Included Guidelines